List View List View   Icon View Icon View

Showing items 1 - 12 of 12.

Add to Quick Collection   All 12 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Title Author/Creator Date Full Text Reviewed
Add Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response Galvao, Daniel A.; Taaffe, Dennis R.; Spry, Nigel; Joseph, David; Newton, Robert U. 2011 — Reviewed
Add Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point Delahunt, Brett; Lamb, David S,; Srigley, John R.; Murray, Judy D,; Wilcox, Chantelle... More 2010 — Reviewed
Add Assuring high quality treatment delivery in clinical trials: results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study Haworth, Annette; Kearvell, Rachel; Greer, Peter B.; Hooton, Ben; Denham, James W.... More 2009 — Reviewed
Add Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial Capp, Anne; Inostroza-Ponta, Mario; Atkinson, Chris; North, John; Poulsen, Michael... More 2009 — Reviewed
Add Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking? Denham, James W.; Steigler, Allison; Gleeson, Paul S.; D'Este, Catherine; Kumar, Mahesh... More 2009 — Reviewed
Add PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer? Denham, James W.; Lamb, David S.; Joseph, David; Matthews, John; Atkinson, Chris... More 2009 — Reviewed
Add A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial Galvão, Daniel A.; Spry, Nigel; Taaffe, Dennis R.; Denham, James; Joseph, David... More 2009 Full Text Reviewed
Add Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer Denham, James W.; Kumar, Mahesh; Turner, Sandra; Greer, Peter B.; D'Este, Catherine... More 2009 — Reviewed
Add Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? Denham, James W.; Steigler, Allison; Wilcox, Chantelle; Lamb, David S.; Joseph, David... More 2009 — Reviewed
Add Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial Denham, James W.; Steigler, Allison; Gleeson, Paul S.; Greer, Peter B.; D'Este, Catherine... More 2008 — Reviewed
Add Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants Haworth, Annette; Ebert, Martin A.; St. Clair, Shaun; Carey, Brendan M.; Flynn, Anthony... More 2005 — Reviewed
Add Prostate implant evaluation using tumour control probability: the effect of input parameters Haworth, Annette; Ebert, Martin; Waterhouse, David; Joseph, David; Duchesne, Gillian 2004 — Reviewed
  • First
  • Previous
  • 1
  • Next
  • Last
Author/Creator
Keyword
Format Type